Evidence map›Paper›PMID 39052707›Full record

ArticleThe Journal of infectious diseases2024

Steroid Drugs Inhibit Bacterial Respiratory Oxidases and Are Lethal Toward Methicillin-Resistant Staphylococcus aureus.

Samantha A Henry, Calum M Webster, Lindsey N Shaw, Nathanial J Torres, Mary-Elizabeth Jobson, Brendan C Totzke, Jessica K Jackson, Jake E McGreig, Mark N Wass, Gary K Robinson and 1 more

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Investigating the role of cytochromeRSC medicinal chemistry · 2026
    Article
  4. Article
  5. Drug Repurposing: An Emerging Strategy inJournal of microbiology and biotechnology · 2025
    Review
  6. Carbon Monoxide and Prokaryotic Energy Metabolism.International journal of molecular sciences · 2025
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Samantha A HenrySchool of Biosciences, University of Kent, Canterbury, United Kingdom.
Calum M WebsterSchool of Biosciences, University of Kent, Canterbury, United Kingdom.
Lindsey N ShawDepartment of Molecular Biosciences, University of South Florida, Tampa.
Nathanial J TorresDepartment of Molecular Biosciences, University of South Florida, Tampa.
Mary-Elizabeth JobsonDepartment of Molecular Biosciences, University of South Florida, Tampa.
Brendan C TotzkeDepartment of Molecular Biosciences, University of South Florida, Tampa.
Jessica K JacksonDepartment of Molecular Biosciences, University of South Florida, Tampa.
Jake E McGreigSchool of Biosciences, University of Kent, Canterbury, United Kingdom.
Mark N WassSchool of Biosciences, University of Kent, Canterbury, United Kingdom.
Gary K RobinsonSchool of Biosciences, University of Kent, Canterbury, United Kingdom.
Mark ShepherdSchool of Biosciences, University of Kent, Canterbury, United Kingdom.ORCID 0000-0002-7472-2300

Funding

Dissecting the Influence of a C-Terminal Processing Protease on S. aureus PathogenesisR01AI157506 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI SHAW, LINDSEY NEIL · 2021 to 2024
$1.5M
National Institute of Allergy and Infectious DiseasesNIAID NIH HHS R01 AI157506
6 · The paper itself

Abstract

backgroundCytochrome bd complexes are respiratory oxidases found exclusively in prokaryotes that are important during infection for numerous bacterial pathogens.

methodsIn silico docking was employed to screen approved drugs for their ability to bind to the quinol site of Escherichia coli cytochrome bd-I. Respiratory inhibition was assessed with oxygen electrodes using membranes isolated from E. coli and methicillin-resistant Staphylococcus aureus strains expressing single respiratory oxidases (ie, cytochromes bd, bo', or aa3). Growth/viability assays were used to measure bacteriostatic and bactericidal effects.

resultsThe steroid drugs ethinylestradiol and quinestrol inhibited E. coli bd-I activity with median inhibitory concentration (IC50) values of 47 ± 28.9 µg/mL (158 ± 97.2 µM) and 0.2 ± 0.04 µg/mL (0.5 ± 0.1 µM), respectively. Quinestrol inhibited growth of an E. coli "bd-I only" strain with an IC50 of 0.06 ± 0.02 µg/mL (0.2 ± 0.07 µM). Growth of an S. aureus "bd only" strain was inhibited by quinestrol with an IC50 of 2.2 ± 0.43 µg/mL (6.0 ± 1.2 µM). Quinestrol exhibited potent bactericidal effects against S. aureus but not E. coli.

conclusionsQuinestrol inhibits cytochrome bd in E. coli and S. aureus membranes and inhibits the growth of both species, yet is only bactericidal toward S. aureus.

Indexed as

Anti-Bacterial AgentsEscherichia coliMethicillin-Resistant Staphylococcus aureusCytochrome b GroupCytochromesElectron Transport Chain Complex ProteinsEscherichia coli ProteinsMicrobial Sensitivity TestsMolecular Docking SimulationOxidoreductasesSteroidsAnti-Bacterial Agentscytochrome bd terminal oxidase complex, E coliCytochrome b GroupCytochromesElectron Transport Chain Complex ProteinsEscherichia coli ProteinsOxidoreductasesSteroidsantimicrobialscytochrome bddrug repurposingMRSAquinestrol

Identifiers

PMID39052707
PMCPMC11272085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.